World Choroidal Neovascularization Market Drivers and Challenges Report 2020

Submitted by: Submitted by

Views: 10

Words: 422

Pages: 2

Category: Business and Industry

Date Submitted: 03/03/2016 04:16 AM

Report This Essay

RnRMarketResearch.com includes Global Choroidal Neovascularization Market 2016-2020 a new research reports in its store. The analysts forecast global choroidal neovascularization market to grow at a CAGR of 6.64% during the period 2016-2020.

Choroidal neovascularization is the formation of new blood vessels in the choroid layer of the eye. These vessels grow through the Bruch membrane into the subretinal space, blocking the proper functioning of retina and leading to vision loss. The condition is often associated with myopia, malignant myopic degeneration, or age-related macular degeneration (AMD).

Inquire on the Report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=494956

The report covers the present scenario and the growth prospects of the global choroidal neovascularization market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment and prevention of choroidal neovascularization.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Purchase a Copy of the Report @ http://www.rnrmarketresearch.com/contacts/discount?rname=494956 (Single User License - US $2500)

The report, Global Choroidal Neovascularization Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors - Bayer HealthCare, Novartis, Regeneron Pharmaceuticals, F. Hoffmann-La Roche

Other prominent vendors – Alcon, Allergan, Avalanche, Bausch and Lomb, Gilead Sciences, Iconic Therapeutics, Lpath, Neurotech Pharmaceuticals, Ohr Pharmaceutical, Opthea, Ophthotech, PanOptica, Pfizer, Promedior,QLT, Quark, Resolvyx Pharmaceuticals, RXi Pharmaceuticals, Sagent Pharmaceuticals, Santen, Sanwa Kagaku...